eightyfour
calv
respiratori
diseas
herd
differ
part
finland
chosen
studi
evalu
capac
differ
respiratori
pathogen
caus
chang
differ
acut
phase
protein
concentr
white
blood
cell
wbc
count
clinic
sign
select
acut
phase
protein
fibrinogen
haptoglobin
serum
amyloida
lipopolysaccharid
bind
protein
glycoprotein
calf
pair
blood
sampl
obtain
serolog
studi
bovin
parainfluenza
bovin
respiratori
syncyti
viru
bovin
coronaviru
bovin
bovin
tracheobronchi
lavag
perform
detect
bacteria
mycoplasma
isol
pasteurella
multocida
associ
increas
concentr
test
acut
phase
protein
articl
press
wwwelseviercomlocatecimid
see
front
matter
r
nikunen
pathogen
signific
relationship
observ
associ
present
viral
bacteri
find
wbc
count
r
acut
phase
respons
apr
set
reaction
earli
protect
mechan
host
infect
trauma
tissu
damag
one
main
featur
hepat
product
acut
phase
protein
app
app
larg
heterogen
group
protein
wide
rang
biolog
activ
mani
function
host
defenc
inflamm
fulli
understood
measur
concentr
differ
app
plasma
give
us
valuabl
inform
apr
cours
diseas
role
profil
differ
app
differ
thu
measur
sever
app
provid
comprehens
pictur
apr
individu
anim
mani
experiment
studi
app
cattl
carri
recent
year
eg
describ
chang
concentr
app
diseas
marker
bovin
clinic
respiratori
diseas
feedlot
calv
experiment
respiratori
infect
model
bovin
respiratori
diseas
brd
multifactori
diseas
cattl
involv
mani
pathogen
app
may
use
explor
impact
differ
etiolog
factor
diseas
complex
knowledg
studi
relationship
differ
app
natur
occur
respiratori
pathogen
calv
conduct
fibrinogen
circul
precursor
fibrin
blood
clot
cascad
first
app
routin
use
cattl
diagnost
protein
mainli
two
articl
press
major
bovin
app
haptoglobin
hp
serum
amyloida
saa
also
test
evalu
apr
cattl
addit
bovin
app
lipopolysaccharid
bind
protein
lbp
moder
respond
glycoprotein
agp
investig
experiment
bacteri
respiratori
infect
calv
object
studi
determin
concentr
differ
app
relat
clinic
sign
white
blood
cell
wbc
count
brd
caus
differ
pathogen
calv
field
condit
eighteen
herd
studi
novemb
decemb
ten
herd
fatten
unit
dairi
herd
farm
locat
eastern
southern
western
finland
fatten
unit
young
cattl
dairi
herd
cow
diseas
calv
mostli
ayrshir
holsteinfriesian
breed
mean
age
calv
rang
day
mean
weight
rang
kg
brd
problem
suspect
herd
anim
owner
contact
veterinarian
farm
visit
veterinarian
examin
calv
clinic
sign
thorough
clinic
examin
conduct
heart
rate
respiratori
rate
determin
rectal
temperatur
measur
descript
respiratori
sound
appear
amount
nasal
discharg
record
cough
note
clinic
examin
calv
examin
diarrhoea
accord
preset
criteria
abnorm
sound
auscult
respiratori
tract
calvesherd
total
calv
chosen
tracheobronchi
lavag
addit
chosen
calv
least
one
follow
symptom
increas
respiratori
rate
rectal
temperatur
cough
nasal
discharg
sever
reason
calv
left
survey
calv
taken
research
tracheobronchi
lavag
blood
sampl
taken
calv
without
sedat
calf
restrain
assist
steril
plastic
doubl
cathet
insert
nostril
ventral
nose
duct
trachea
doubl
cathet
insid
trachea
inner
cathet
push
silicon
plug
outer
cathet
lung
far
possibl
thirti
forti
millilitr
steril
phosphatebuff
salin
pb
dulbecco
phosphatebuff
salin
gibco
tm
invitrogen
corpor
paisley
scotland
uk
inject
cathet
immedi
aspir
sampl
divid
test
tube
glucos
calf
serum
broth
gs
isol
mycoplasma
transport
media
portagerm
multitransport
medium
biomerieux
lyon
franc
isol
bacteria
rest
sampl
frozen
analys
blood
sampl
serolog
test
determin
wbc
count
app
fibrinogen
hp
saa
lbp
agp
taken
diseas
calv
second
sampl
serolog
collect
calv
week
later
pair
serum
sampl
calv
sampl
could
obtain
analys
properli
includ
studi
handl
blood
sampl
describ
elsewher
tracheobronchi
lavag
sampl
examin
bacteri
growth
nation
veterinari
food
research
institut
helsinki
accord
standard
procedur
describ
detail
elsewher
mycoplasma
sampl
kept
frozen
cultur
media
cultur
identif
method
use
report
elsewher
serum
sampl
test
antibodi
bovin
parainfluenza
bovin
respiratori
syncyti
viru
brsv
bovin
coronaviru
bcv
bovin
bovin
bovin
exist
finland
bovin
viru
diarrhoea
rare
virus
exclud
research
panel
elisa
test
use
antibodi
brsv
bcv
viru
neutral
test
use
elisa
kit
svanova
biotech
uppsala
sweden
use
accord
manufactur
instruct
fourfold
increas
antibodi
titr
neutral
test
seen
elisa
test
seroneg
first
sampl
seroposit
second
sampl
calf
consid
rise
titr
recent
infect
respect
viru
fibrinogen
concentr
plasma
determin
heat
precipit
method
serum
hp
determin
use
haemoglobinbind
assay
describ
makimura
suzuki
modif
tetramethylbenzidin
mgml
use
substrat
serum
saa
measur
commerci
avail
elisa
kit
phase
saa
kit
tridelta
ltd
ireland
accord
manufactur
instruct
cattl
serum
agp
analys
use
commerci
radial
immunodiffus
kit
manufactur
eco
institut
furukawa
miyagi
japan
serum
lbp
commerci
elisa
kit
use
lbp
elisa
variou
speci
hycult
biotechnolog
uden
netherland
wbc
count
determin
automat
cell
counter
adjust
anim
cell
count
coultercount
model
coulter
electron
ltd
luton
uk
result
number
observ
less
five
ie
bcv
arcanobacterium
pyogen
exclud
statist
analysi
linear
regress
analysi
use
studi
relationship
result
seroconvers
test
mycoplasm
find
mycoplasma
dispar
mycoplasma
sp
bacteri
find
pasteurella
multocida
fusobacterium
nechrophorum
well
clinic
sign
concentr
app
wbc
count
respons
variabl
dichotom
cough
diarrhoea
chang
respiratori
sound
nasal
discharg
logist
regress
analysi
appli
logarithm
transform
use
achiev
normal
distribut
app
wbc
count
pvalu
less
consid
signific
statist
analys
carri
use
statist
packag
social
scienc
spss
window
version
spss
inc
chicago
il
usa
seroconvers
virus
bcv
brsv
observ
calv
respect
dispar
mycoplasma
p
multocida
pasteurella
sp
f
necrophorum
pyogen
could
isol
calv
respect
mycoplasma
bovi
found
diarrhoea
increas
rectal
temperatur
increas
respiratori
rate
crackl
respiratori
sound
cough
nasal
discharg
present
calv
respect
associ
p
multocida
elev
respiratori
rate
increas
rectal
temperatur
crackl
respiratori
sound
nasal
discharg
found
neg
associ
seroconvers
crackl
respiratori
sound
seen
isol
p
multocida
associ
increas
concentr
test
app
tabl
pathogen
signific
relationship
observ
associ
present
viral
bacteri
find
wbc
count
p
multocida
common
bacterium
found
lavag
fluid
calv
mannheimia
haemolytica
formerli
pasteurella
haemolytica
detect
accord
studi
p
multocida
haemolytica
predomin
bacteria
associ
brd
signific
result
relationship
presenc
p
multocida
clinic
sign
increas
concentr
app
indic
strong
pathogen
role
p
multocida
respiratori
diseas
calv
finland
least
situat
known
pathogen
eg
haemolytica
bovi
brsv
absent
result
agre
experiment
studi
calv
p
multocida
report
caus
gener
symptom
well
increas
concentr
app
hp
saa
agp
increas
concentr
agp
report
gradual
remain
elev
longer
observ
saa
hp
haemolytica
caus
increas
concentr
hp
fibrinogen
plasma
well
fever
note
associ
test
virus
clinic
sign
app
despit
viral
seroconvers
suggest
weak
role
virus
brd
although
virus
seem
caus
apr
directli
clear
clinic
sign
may
still
role
predispos
factor
bacteri
invas
neg
associ
seroconvers
crackl
respiratori
sound
difficult
explain
may
coincident
calv
particip
studi
approxim
month
old
reliabl
antibodi
determin
base
tabl
serum
blood
concentr
mean
pvalu
fibrinogen
fib
gl
haptoglobin
hp
gl
serum
amyloid
saa
mgl
glycoprotein
agp
mgl
lipopolysaccharid
bind
protein
lbp
mgl
white
blood
cell
wbc
l
calv
respiratori
diseas
without
pasteurella
multocida
tracheobronchi
lavag
fluid
igg
serum
calv
less
month
age
question
matern
antibodi
might
interfer
seroconvers
result
concern
viral
seroconvers
thu
interpret
caution
despit
mycoplasma
sp
dispar
isol
herd
calv
associ
mycoplasma
clinic
sign
observ
agreement
earlier
find
tanskanen
howev
report
dispar
caus
clinic
sign
includ
slight
temperatur
rise
intermitt
cough
nasal
discharg
calv
experiment
infect
model
experiment
studi
viral
bacteri
respons
compar
fibrinogen
hp
saa
respond
faster
haemolytica
infect
bvdv
infect
respons
last
longer
agent
present
concentr
fibrinogen
hp
increas
even
durat
respons
prolong
hp
consid
distinguish
marker
viral
bacteri
diseas
rise
significantli
bacteri
infect
howev
experiment
infect
rsv
author
also
report
high
hp
valu
likewis
virem
stage
footandmouth
diseas
studi
use
differ
app
marker
natur
occur
respiratori
diseas
somewhat
controversi
hp
report
use
detect
calv
respiratori
diseas
requir
treatment
monitor
efficaci
treatment
research
found
hp
limit
capac
clinic
tool
diagnost
respiratori
diseas
feedlot
cattl
although
saa
lbp
shown
sensit
app
hp
studi
conclud
saa
use
marker
respiratori
diseas
field
condit
serum
saa
concentr
report
influenc
physic
stress
may
partial
explain
variabl
behaviour
studi
establish
rank
differ
app
marker
respiratori
diseas
calv
difficult
associ
exist
app
p
multocida
tabl
nevertheless
associ
p
multocida
lbp
fibrinogen
seem
slightli
stronger
app
measur
howev
may
due
sever
confus
reason
peak
concentr
differ
app
occur
differ
stage
infect
andor
pathogen
inductor
caus
variabl
respons
differ
app
fibrinogen
long
routin
use
prove
use
easi
inexpens
test
confirm
presenc
infect
wbc
count
contrast
correl
well
type
brd
thu
use
clinic
purpos
situat
studi
confirm
strong
pathogen
role
p
multocida
valu
app
explor
respiratori
diseas
calv
field
condit
dairi
cooper
pfizer
anim
health
hoechst
fennica
grate
acknowledg
